The δ1 opioid receptor is a heterodimer that opposes the actions of the δ2 receptor on alcohol intake

Biological Psychiatry

Volumn 66, Issue 8, 2009, Pages 777-784

  Van Rijn, Richard M ^a   Whistler, Jennifer L ^a  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

Author keywords

Alcoholism; Delta opioid receptor; Ethanol; G protein coupled receptor; Heterodimerization; Subtypes

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 7 BENZYLIDENENALTREXONE; ALCOHOL; ALCOHOL DEHYDROGENASE; CALCIUM ION; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; G PROTEIN COUPLED RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTREXONE; NALTRIBEN; NALTRINDOLE; NICOTINAMIDE; OPIATE AGONIST; OPIATE ANTAGONIST; RECEPTOR SUBTYPE; TRITIUM; DOR 1 PROTEIN, MOUSE; DOR-1 PROTEIN, MOUSE; NARCOTIC ANTAGONIST;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; BIOTINYLATION; CALCIUM MOBILIZATION; CELL STRAIN HEK293; CONDITIONING; CONTROLLED STUDY; DIMERIZATION; DRINKING BEHAVIOR; DRUG EFFECT; DRUG SELECTIVITY; DRUG TARGETING; HUMAN; HUMAN CELL; LIGAND BINDING; LOCOMOTION; MOUSE; NEUROPHARMACOLOGY; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; ANIMAL; ANIMAL BEHAVIOR; BLOOD; C57BL MOUSE; DECISION MAKING; DRUG ANTAGONISM; DRUG POTENTIATION; GENETICS; MALE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PROTEIN MULTIMERIZATION;

ALCOHOL DRINKING; ANIMALS; BEHAVIOR, ANIMAL; CHOICE BEHAVIOR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NARCOTIC ANTAGONISTS; PROTEIN MULTIMERIZATION; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 72449140688     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.05.019     Document Type: Article

References (50)

1. van Ree JM, Gerrits MA, Vanderschuren LJ (1999): Opioids, reward and addiction: An encounter of biology, psychology, and medicine. Pharmacol Rev 51:341-396.
2. Waldhoer M, Bartlett SE, Whistler JL (2004): Opioid receptors. Annu Rev Biochem 73:953-990.
3. Froehlich JC, Li TK (1994): Opioid involvement in alcohol drinking. AnnN Y Acad Sci 739:156-167.
4. Rohsenow DJ (2004): What place does naltrexone have in the treatment of alcoholism? CNS Drugs 18:547-560.
5. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. (2006): Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. J Am Med Assoc 295:2003-2017.
6. Hall FS, Sora I, Uhl GR (2001): Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology 154:43-49.
7. Kovacs KM, Szakall I, O'Brien D, Wang R, Vinod KY, Saito M, et al. (2005): Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcohol Clin Exp Res 29:730-738.
8. Roberts AJ, Gold LH, Polis I, McDonald JS, Filliol D, Kieffer BL, et al. (2001): Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol Clin Exp Res 25:1249-1256.
9. Evans CJ, Keith DE Jr., Morrison H, Magendzo K, Edwards RH (1992): Cloning of a delta Opioid receptor by functional expression. Science 258:1952-1955.
10. Simonin F, Befort K, Gaveriaux-Ruff C, Matthes H, Nappey V, Lannes B, et al. (1994): The human delta-opioid receptor: Genomic organization, cDNA cloning, functional expression, and distribution in human brain. Mol Pharmacol 46:1015-1021.
11. Zaki PA, Bilsky EJ, Vanderah TW, Lai J, Evans CJ, Porreca F (1996): Opioid receptor types and subtypes: The delta receptor as a model. Annu Rev Pharmacol Toxicol 36:379-401. (Pubitemid 26168704)
12. Mattia A, Vanderah T, Mosberg HI, Porreca F (1991): Lack of antinociceptive cross-tolerance betweenD-Pen2, D-Pen5enkephalinandD- Ala2deltorphin II in mice: Evidence for delta receptor subtypes. J Pharmacol Exp Ther 258: 583-587.
13. Le AD, Poulos CX, Quan B, Chow S (1993): The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res 630:330-332.
14. Krishnan-Sarin S, Jing SL, Kurtz DL, Zweifel M, Portoghese PS, Li TK, et al. (1995): The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference. Psychopharmacology (Berl) 120:177-185.
15. Krishnan-Sarin S, Portoghese PS, Li TK, Froehlich JC (1995): The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol Biochem Behav 52:153-159.
16. June HL, McCane SR, Zink RW, Portoghese PS, Li TK, Froehlich JC (1999): The delta 2-opioid receptor antagonist naltriben reduces motivated responding for ethanol. Psychopharmacology (Berl) 147:81-89.
17. Froehlich JC, Zweifel M, Harts J, Lumeng L, Li TK (1991): Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology 103:467-472.
18. Franck J, Lindholm S, Raaschou P (1998): Modulation of volitional ethanol intake in the rat by central delta-opioid receptors. Alcohol Clin Exp Res 22:1185-1189.
19. Williams KL, Woods JH (1998): Oral ethanol-reinforced responding in rhesus monkeys: Effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor. Alcohol Clin Exp Res 22:1634-1639.
20. Stromberg MF, Casale M, Volpicelli L, Volpicelli JR, O'Brien CP (1998): A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat. Alcohol 15:281-289.
21. Middaugh LD, Kelley BM, Groseclose CH, Cuison ER Jr (2000): Deltaopioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL/6 mice. Pharmacol Biochem Behav 65:145-154.
22. Hyytia P (1993): Involvement of mu-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol Biochem Behav 45:697-701.
23. Honkanen A, Vilamo L, Wegelius K, Sarviharju M, Hyytia P, Korpi ER (1996): Alcohol drinking is reduced by a mu 1-but not by a delta-opioid receptor antagonist in alcohol-preferring rats. Eur J Pharmacol 304:7-13.
24. Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, et al. (1994): Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol 45:330-334.
25. Parkhill AL, Bidlack JM (2002): Several delta-opioid receptor ligands display no subtype selectivity to the human delta-opioid receptor. Eur J Pharmacol 451:257-264.
26. Jordan BA, Devi LA (1999): G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697-700.
27. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, et al. (2000): Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 275:26128-26135.
28. Zapata: A, Gonzales RA, Shippenberg TS (2006): Repeated ethanol intoxication induces behavioral sensitization in the absence of a sensitized accumbens dopamine response in C57BL/6J and DBA/2J mice. Neuropsychopharmacology 31:396-405.
29. Waldhoer M, Fong J, Jones RM, Lunzer MM, Sharma SK, Kostenis E, et al. (2005): A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci U S A 102:9050-9055.
30. Gharagozlou P, Demirci H, Clark JD, Lameh J (2002): Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors. BMC Neurosci 3:19.
31. Kieffer BL, Gaveriaux-Ruff C (2002): Exploring the opioid system by gene knockout. Prog Neurobiol 66:285-306.
32. Roberts AJ, McDonald JS, Heyser CJ, Kieffer BL, Matthes HW, Koob GF, et al. (2000): Mu-opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther 293:1002-1008.
33. Yoneyama N, Crabbe JC, Ford MM, Murillo A, Finn DA (2008): Voluntary ethanol consumption in 22 inbred mouse strains. Alcohol 42:149-160.
34. Pellegrino SM, Druse MJ (1992): The effects of chronic ethanol consumption on the mesolimbic and nigrostriatal dopamine systems. Alcohol Clin Exp Res 16:275-280.
35. Mendez M, Morales-Mulia M, Leriche M (2004): 3HDPDPE binding to delta opioid receptors in the rat mesocorticolimbic and nigrostriatal pathways is transiently increased by acute ethanol administration. Brain Res 1028:180-190.
36. Sofuoglu M, Portoghese PS, Takemori AE (1993): 7-Benzylidenenaltrexone (BNTX): A selectivedelta1 opioid receptor antagonist in the mouse spinal cord. Life Sciences 52:769-775.
37. Middaugh LD, Bandy AL (2000): Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice. Psychopharmacology 151:321-327.
38. Phillips TJ, Wenger CD, Dorow JD (1997): Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice. Alcohol Clin Exp Res 21:691-702.
39. Porreca F, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI (1992): Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J Pharmacol Exp Ther 263:147-152.
40. Matthes HWD, Smadja C, Valverde O, Vonesch JL, Foutz AS, Boudinot E, et al. (1998): Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the μ-receptor. J Neurosci 18:7285-7295.
41. Portoghese PS, LunzerMM(2003): Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord. Eur J Pharmacol 467:233-234.
42. Bhushan RG, Sharma SK, Xie Z, Daniels DJ, Portoghese PS (2004): A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers. J Med Chem 47: 2969-2972.
43. Breit A, Lagace M, Bouvier M (2004): Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem 279: 28756-28765.
44. Hasbi A, Nguyen T, Fan T, Cheng R, Rashid A, Alijaniaram M, et al. (2007): Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: Coregulation by agonists. Biochemistry 46:12997-13009.
45. Hack SP, Bagley EE, Chieng BCH, Christie MJ (2005): Induction of deltaopioid receptor function in the midbrain after chronic morphine treatment. J Neurosci 25:3192-3198.
46. Ma J, Zhang Y, Kalyuzhny AE, Pan ZZ (2006): Emergence of functional delta-opioid receptors induced by long-term treatment with morphine. Mol Pharmacol 69:1137-1145.
47. Cahill CM, Morinville A, Hoffert C, O'Donnell D, Beaudet A (2003): Upregulation and trafficking of delta opioid receptor in a model of chronic inflammation: Implications for pain control. Pain 101:199-208.
48. Commons KG (2003): Translocation of presynaptic delta opioid receptors in the ventrolateral periaqueductal gray after swim stress. J Comp Neurol 464:197-207.
49. Cahill CM, Morinville A, Lee MC, Vincent JP, Collier B, Beaudet A (2001): Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci 21:7598-7607.
50. Charness ME, Hu G, Edwards RH, Querimit LA (1993): Ethanol increases delta-opioid receptor gene expression in neuronal cell lines. Mol Pharmacol 44:1119-1127.